Dovitinib
| CAS No. | 405169-16-6 |
|---|---|
| MDL No. | MFCD10565680 |
| MF | C21H21FN6O |
| MW | 392.40 |
| InChI Key | PIQCTGMSNWUMAF-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone is an N-arylpiperazine.
| CAS No. | 405169-16-6 |
|---|---|
| Product Name | Dovitinib |
Biological Targets
FGFR3·PDGFRB·PDGFRA·KIT·FLT3·
Associated Conditions
triple-negative breast cancer·glioblastoma multiforme·endometrial cancer·cancer·neoplasm·
* The information provided here is compiled from public sources and is for reference only.
